Dr. E shares a case study from an MDI LADA patient, pointing out successes in his regimen along with recommendations for improvement.
read more →
History has just been made! The FDA recently approved a new treatment therapy called Tzield that works to prevent or delay the onset of type 1 diabetes. People at a high risk of developing type 1 can now delay its onset for years, giving them valuable time to learn about the condition and how to manage it safely.
read more →
Vertex Pharmaceuticals is relatively new to the type 1 diabetes space, and they are working hard to understand what it’s like for people to live with T1D so they can develop transformative therapies. They’re currently investigating and advancing cell therapies aimed at treating an underlying cause of type 1 – the absence of insulin-producing cells.
read more →
Dr. Ian Paterson, a medical practitioner at the University of Sheffield who lives with T1D, explains how the “honeymoon phase” that often occurs with type 1 can potentially be used to delay its full development, and why it’s important to preserve even a small number of functioning beta cells if you can.
read more →
Do you know it’s now possible to screen for type 1 diabetes? Learn why it could be important for you and your family, and how it can help you understand more about the risks, development, and progression of T1D.
read more →
